Drugs Made In America Acquisition Corp. (DMAA) earnings
Quarterly results of Drugs Made In America Acquisition Corp. as filed with the SEC: revenue, net income and earnings per share for each of the last 7 quarters, the latest results release and when the next one is expected.
Next earnings date
Drugs Made In America Acquisition Corp. is expected to report around November 17, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Drugs Made In America Acquisition Corp. reported revenue of - and net income of $1.7M (-24.5% on the same quarter a year earlier).
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | - | - | $1.7M | - |
| Q1 FY2026 | - | - | $2M | - |
| Q4 FY2025 | - | - | $213K | - |
| Q3 FY2025 | - | - | $2.2M | - |
| Q2 FY2025 | - | - | $2.3M | - |
| Q1 FY2025 | - | - | $1.3M | - |
| Q3 FY2025 | - | - | -$144.9K | - |
Results filings
- Quarterly report 10-Q
- Quarterly report 10-Q
- Annual report 10-K
When is Drugs Made In America Acquisition Corp.'s next earnings date?
Drugs Made In America Acquisition Corp. is expected to report around November 17, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
Get an email when DMAA reports
Follow DMAA and we email you its next results the day they are filed, with the numbers explained.